Showing results (291-300 of 331) with videos related to
Sort By:
Pageof 34
Oncology Reports|December 3, 2011
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancerGerda Hofstetter, Astrid Berger, Eva-Maria Bauer, et al.Journal of Clinical Medicine|April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 RegistryFlorian Huemer, Lukas Weiss, Peter Regitnig, et al.Cancer Causes & Control : CCC|December 9, 2010
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative studyWegene Borena, Tanja Stocks, Håkan Jonsson, et al.Gynecologic Oncology|February 15, 2012
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can)Hanno Ulmer, Tone Bjørge, Hans Concin, et al.Plos One|March 4, 2014
A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative studyWegene Borena, Michael Edlinger, Tone Bjørge, et al.Plos One|February 2, 2013
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)Susanne Strohmaier, Michael Edlinger, Jonas Manjer, et al.Frontiers in Cardiovascular Medicine|February 19, 2024
Complexity of coronary artery disease and the release of cardiac biomarkers after CABGLeo Pölzl, Ronja Lohmann, Philipp Sterzinger, et al.BMC Cancer|November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.Therapeutic Advances in Respiratory Disease|June 3, 2018
Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical studyRoland Arnitz, Markus Stein, Petra Bauer, et al.Cancer Research|April 15, 2010
Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancerAlexander M Strasak, Georg Goebel, Hans Concin, et al.Pageof 34